United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Products
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone AT161-8)
| Applications | FC, IF |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone AT161-10)
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-CD40 (Clone chi220)
| Applications | Bl |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone MR1)
| Applications | Bl, FC, FN |
| Reactivities | Mouse |
Recombinant Anti-CD40L (Clone MR1)
| Applications | Bl, FC, FN |
| Reactivities | Mouse |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone AT161-8)
| Applications | FC, IF |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone AT161-10)
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-CD40 (Clone chi220)
| Applications | Bl |
| Reactivities | Human |
CNY 7,170.00
6周
Recombinant Anti-CD154 (Clone IDEC-131 (Toralizumab))
| Applications | IF |
| Reactivities | Human |
CNY 7,170.00
6周
Recombinant Anti-CD154 (Clone IDEC-131 (Toralizumab))
| Applications | IF |
| Reactivities | Human |
